Long-Term Liabilities: The sum of all non-current liabilities.
89BIO (ETNB) had Long-Term Liabilities of $41.77M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-367.08M |
|
-- |
|
-- |
|
$384.66M |
|
$-384.66M |
|
$18.27M |
|
$-366.39M |
|
$-366.39M |
|
$-367.08M |
|
$-367.08M |
|
$-367.08M |
|
$-367.08M |
|
$-384.66M |
|
$-393.76M |
|
104.72M |
|
104.72M |
|
$-3.51 |
|
$-3.51 |
|
| Balance Sheet Financials | |
$476.45M |
|
$0.02M |
|
$2.23M |
|
$478.69M |
|
$36.13M |
|
$35.73M |
|
|
Long-Term Liabilities |
$41.77M |
$77.90M |
|
$400.79M |
|
$400.79M |
|
$400.79M |
|
119.85M |
|
| Cash Flow Statement Financials | |
$-367.82M |
|
$-40.86M |
|
$218.59M |
|
$316.16M |
|
$126.06M |
|
$-190.10M |
|
$20.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.19 |
|
-- |
|
-- |
|
0.08 |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-367.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-91.59% |
|
-91.59% |
|
-76.68% |
|
-84.09% |
|
$3.34 |
|
$-3.51 |
|
$-3.51 |
|